• Ranbaxy Laboratories, Ltd. / Ranbaxy, Inc. v. Vertex Pharmaceuticals, Inc.Other
  PTAB · Nov 15, 2013 · IPR2013-00024 · APJ Sally Gardner Lane · IPR · Order

  The Board granted the parties’ joint motion and terminated the proceeding after settlement, without issuing a final written decision.

  RulingsOther

  • PTAB / AIA Trials › Other PTAB motions (exclude, strike, seal, additional discovery, rehearing)Granted

    “The parties indicate that they have reached settlement and jointly move to terminate this trial proceeding. (Joint Motion (Paper 69) filed 31 October 2013). See 35 U.S.C. § 317(a); 37 C.F.R. § 42.72. The parties have filed under seal a copy of the written Settlement Agreement. (Exhibit 3001 (attached to the Joint Motion as Exhibit A)). The parties represent that “[t]here is no related litigation between the parties” (Joint Motion at 3).1” slip op. at 2

  None
  Patents in suitUS 6,436,989

Holdings, summaries, rulings, issues, outcomes, winners and claim constructions shown for a decision were generated by a large language model reading the opinion. They are a guide to the decision, not the decision. Confirm every one against the court's own text before relying on it. Outcomes read from the patent owner’s side. Party names are extracted from the decision and are missing on about 900 short Director denials and scans, which carry the trial number instead.